Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance

被引:144
作者
Bray, PG
Martin, RE
Tilley, L
Ward, SA
Kirk, K
Fidock, DA
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Univ Liverpool Liverpool Sch Trop Med, Mol & Biochem Parasitol Grp, Liverpool L3 5QA, Merseyside, England
[3] Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT, Australia
关键词
D O I
10.1111/j.1365-2958.2005.04556.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies have highlighted the importance of a parasite protein referred to as the chloroquine resistance transporter (PfCRT) in the molecular basis of Plasmodium falciparum resistance to the quinoline antimalarials. PfCRT, an integral membrane protein with 10 predicted transmembrane domains, is a member of the drug/metabolite transporter superfamily and is located on the membrane of the intra-erythrocytic parasite's digestive vacuole. Specific polymorphisms in PfCRT are tightly correlated with chloroquine resistance. Transfection studies have now proven that pfcrt mutations confer verapamil-reversible chloroquine resistance in vitro and reveal their important role in resistance to quinine. Available evidence is consistent with the view that PfCRT functions as a transporter directly mediating the efflux of chloroquine from the digestive vacuole.
引用
收藏
页码:323 / 333
页数:11
相关论文
共 77 条
  • [1] Substrate recognition by nucleotide sugar transporters - Further characterization of substrate recognition regions by analyses of UDP-galactose/CMP-sialic acid transporter chimeras and biochemical analysis of the substrate specificity of parental and chimeric transporters
    Aoki, K
    Ishida, N
    Kawakita, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (25) : 22887 - 22893
  • [2] Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH
    Bennett, TN
    Kosar, AD
    Ursos, LMB
    Dzekunov, S
    Sidhu, ABS
    Fidock, DA
    Roepe, PD
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2004, 133 (01) : 99 - 114
  • [3] REVERSAL OF CHLOROQUINE RESISTANCE IN MALARIA PARASITE PLASMODIUM-FALCIPARUM BY DESIPRAMINE
    BITONTI, AJ
    SJOERDSMA, A
    MCCANN, PP
    KYLE, DE
    ODUOLA, AMJ
    ROSSAN, RN
    MILHOUS, WK
    DAVIDSON, DE
    [J]. SCIENCE, 1988, 242 (4883) : 1301 - 1303
  • [4] A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum
    Bray, PG
    Ward, SA
    [J]. PHARMACOLOGY & THERAPEUTICS, 1998, 77 (01) : 1 - 28
  • [5] Further comments on the distribution of acridine orange fluorescence in P-falciparum-infected erythrocytes
    Bray, PG
    Saliba, KJ
    Davies, JD
    Spiller, DG
    White, MRH
    Kirk, K
    Ward, SA
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2002, 119 (02) : 311 - 313
  • [6] Access to hematin: The basis of chloroquine resistance
    Bray, PG
    Mungthin, M
    Ridley, RG
    Ward, SA
    [J]. MOLECULAR PHARMACOLOGY, 1998, 54 (01) : 170 - 179
  • [7] Distribution of acridine orange fluorescence in Plasmodium falciparum-infected erythrocytes and its implications for the evaluation of digestive vacuole pH
    Bray, PG
    Saliba, KJ
    Davies, JD
    Spiller, DG
    White, MRH
    Kirk, K
    Ward, SA
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2002, 119 (02) : 301 - 304
  • [8] Bray PG, 1996, MOL PHARMACOL, V50, P1551
  • [9] Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum
    Bray, PG
    Janneh, O
    Raynes, KJ
    Mungthin, M
    Ginsburg, H
    Ward, SA
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 145 (02) : 363 - 376
  • [10] Bray PG, 1996, MOL PHARMACOL, V50, P1559